6-K ·Filed May 28, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the reconvened meeting on June 4 for any shareholder proposals or voting outcomes that could affect governance or capital structure. No immediate trading action warranted.
Final — all horizons settled through T+60d
CANF ▲ 0.00% at T+60d
NEUTRAL call 0.00% · α vs SPY -1.18% · entry $3.35 → $3.35
T+1d
-3.28%
call -3.28% · α -3.54%
$3.24
settled 5mo ago
T+5d
-7.76%
call -7.76% · α -5.26%
$3.09
settled 5mo ago
T+20d
-12.84%
call -12.84% · α -11.04%
$2.92
settled 4mo ago
T+60d
0.00%
call 0.00% · α -1.18%
$3.35
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Can-Fite BioPharma's 2026 Annual General Meeting of Shareholders was adjourned due to lack of quorum and rescheduled for June 4, 2026. This is a routine procedural event with no material financial or operational impact.
Key Facts
- Annual General Meeting convened on May 28, 2026 was adjourned for one week due to lack of quorum.
- Meeting reconvened on June 4, 2026 at 3:00 p.m. Israel time at company offices.
- No proposals, voting results, or business conducted were disclosed in the filing.
Financial Impact
No financial impact — adjournment is a procedural delay only.
Risk Factors
- Lack of quorum may indicate low shareholder engagement, but no direct financial risk.
- No material business was disclosed; adjournment alone is not a catalyst.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-062151 |
| Document: 0001213900-26-062151-index-headers.html | 0001213900-26-062151 |
| Document: 0001213900-26-062151-index.html | 0001213900-26-062151 |
| Document: 0001213900-26-062151.txt | 0001213900-26-062151 |
33 reports for CANF
71% Hit rate @ T+5 Went positive at some point 11 of 14 best @ T+20▲ +15.22%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $1.72 | awaiting T+5 | — | $1.65 (−4.07%) |
Oct 13, 2026 14d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.65 (+15.38%) |
Oct 13, 2026 14d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.65 (+15.38%) |
Sep 14, 2026 6w ago | EFFECT | $2.30 $2.22 | ▲ +3.48% | ▲ +3.58% | $1.65 (+28.26%) |
Sep 9, 2026 6w ago | 6-K | $2.19 $2.24 | ▲ +2.28% | ▲ +3.38% | $1.65 (−24.66%) |
Sep 3, 2026 7w ago | 6-K | $2.35 $2.33 | ▼ −0.85% | ▲ +0.30% | $1.65 (−29.79%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.65 (−30.08%) |
Sep 2, 2026 7w ago | Press Release | $2.36 $2.16 | ▲ +8.47% | ▲ +7.52% | $1.65 (+30.08%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.65 (−30.08%) |
Aug 17, 2026 10w ago | 6-K | $3.58 $3.35 | ▼ −6.42% | ▼ −5.23% | $1.65 (−53.91%) |
Showing 10 of 33
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers